Additional benefit of lamivudine treatment as a preventive therapy for hepatic encephalopathy in patients with decompensated liver cirrhosis associated with hepatitis B

  • Authors:
    • Shinichiro Hanada
    • Ryukichi Kumashiro
    • Ryohei Kaji
    • Masaru Harada
    • Michio Sata
  • View Affiliations

  • Published online on: November 1, 2002     https://doi.org/10.3892/ijmm.10.5.647
  • Pages: 647-648
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Lamivudine has previously been found to be effective not only in patients with compensated liver disease due to hepatitis B virus (HBV) but also in those with hepatic decompensation. However, long-term follow-up of patients with hepatic encephalopathy (HE) has not been previously reported. We describe a patient with recurrent HE associated with decompensated liver cirrhosis due to hepatitis B. After the initiation of treatment with lamivudine, manifestation of HE has not been observed for about 2 years and liver function has improved as well. This experience suggests that improved liver function using lamivudine may contribute to prevention from recurrence of HE.

Related Articles

Journal Cover

November 2002
Volume 10 Issue 5

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Hanada S, Kumashiro R, Kaji R, Harada M and Sata M: Additional benefit of lamivudine treatment as a preventive therapy for hepatic encephalopathy in patients with decompensated liver cirrhosis associated with hepatitis B. Int J Mol Med 10: 647-648, 2002
APA
Hanada, S., Kumashiro, R., Kaji, R., Harada, M., & Sata, M. (2002). Additional benefit of lamivudine treatment as a preventive therapy for hepatic encephalopathy in patients with decompensated liver cirrhosis associated with hepatitis B. International Journal of Molecular Medicine, 10, 647-648. https://doi.org/10.3892/ijmm.10.5.647
MLA
Hanada, S., Kumashiro, R., Kaji, R., Harada, M., Sata, M."Additional benefit of lamivudine treatment as a preventive therapy for hepatic encephalopathy in patients with decompensated liver cirrhosis associated with hepatitis B". International Journal of Molecular Medicine 10.5 (2002): 647-648.
Chicago
Hanada, S., Kumashiro, R., Kaji, R., Harada, M., Sata, M."Additional benefit of lamivudine treatment as a preventive therapy for hepatic encephalopathy in patients with decompensated liver cirrhosis associated with hepatitis B". International Journal of Molecular Medicine 10, no. 5 (2002): 647-648. https://doi.org/10.3892/ijmm.10.5.647